Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2000
09/13/2000EP1034265A1 Human cdc10 homolog
09/13/2000EP1034264A1 Splice variants for human 5-ht 4? serotonin receptor and their applications, in particular for screening
09/13/2000EP1034261A2 Method of parallel screening for insertion mutants and a kit to perform this method
09/13/2000EP1034259A1 Cloning method by multiple digestion, vectors for implementing same and applications
09/13/2000EP1034258A2 Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell
09/13/2000EP1034253A1 Gram negative coccoid bacterium
09/13/2000EP1034221A1 Dibenzorhodamine dyes useful as fluorescent labelling agents
09/13/2000EP1034040A2 Devices and methods for detecting target molecules in biological samples
09/13/2000EP1034004A1 Recombinant mycoplasma hyopneumoniae vaccine
09/13/2000EP1007649A4 Methods to screen for transcription factor-coactivator interactions
09/13/2000EP0938557B1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
09/13/2000EP0832207B1 A method for identification of biologically active peptides and nucleic acids
09/13/2000EP0826066B1 Methods and reagents for combined pcr amplification and hybridization probing assay
09/13/2000EP0765400B1 Screen for inhibitors of chitinase
09/13/2000EP0672110B1 Testing device for liquid and liquid suspended samples
09/13/2000EP0586570B1 Backbone modified oligonucleotide analogues
09/13/2000EP0514488B1 Retinoid receptor compositions and methods
09/13/2000CN1266538A Retentate chromatography and protein chip arrays applications in biology and medicine
09/13/2000CN1266537A Retentate chromatography and protein chip arrays with applications in biology and medicine
09/13/2000CN1266461A Composition, kit, and method for detecting helicobacter pylori in biopsy
09/13/2000CN1266456A Kinase activating dependent cyclin protein kinases, and their uses
09/13/2000CN1266351A Control of enterohemorrhagic E Coli 0157 : H7 in cattle by probiotic bacteria
09/13/2000CN1266104A Multiple normalizing gene amplification method
09/13/2000CN1266098A Growth mark regulated by growth hormone
09/13/2000CN1056382C Improved HCV diagnostic agents
09/12/2000US6118126 Method for enhancing fluorescence
09/12/2000US6117989 Human calcium-binding proteins
09/12/2000US6117981 Hybridomas for lung cancer marker and monoclonal antibodies thereof
09/12/2000US6117978 Protein having at least 63% identity to human protein having defined amino acid sequence; for diagnosis and therapy of alzheimer's disease; drug screening
09/12/2000US6117975 Amino acid and nucleotide sequences; for therapy
09/12/2000US6117973 Peptide nucleic acid monomers; for use as probes to detect nucleic acids
09/12/2000US6117848 Antisense oligonucleotide inhibition of ras
09/12/2000US6117847 For use in inhibiting the function of nucleic acid molecules encoding protein kinase c (pkc), ultimately modulating the amount of pkc produced; for treating cancer, inflammation, psoriasis
09/12/2000US6117839 For increasing bone growth in mammals
09/12/2000US6117679 Adjusting polynucleotide sequences; amplifying nucleotide sequences and screening a recombinant polynucleotide for a desired property
09/12/2000US6117675 Retinal stem cells
09/12/2000US6117662 Respiratory nitrate reductase alpha subunit
09/12/2000US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents
09/12/2000US6117650 Testing sample for defects heart muscle activity; coat well with nutrients, plate muscle cells, culture cells, insert test sample into culture, culture cells, monitor adjustment in cell size and release of atrial natriuretic protein
09/12/2000US6117649 Genetically engineered yeast strains
09/12/2000US6117648 Method for the activation of blood coagulation factor XII
09/12/2000US6117641 Assays and reagents for identifying anti-fungal agents and uses related thereto
09/12/2000US6117639 Screening for enzyme inhibitors against proteases, determining inhibitory activity; novel transcriptional assay using DNA molecules encoding the fusion protein substrates; Hepatitis C Virus NS3 protease or HIV aspartyl protease
09/12/2000US6117638 Detection of test compounds that modulate gene expression by triggering activation; incubation of nucleic acids with a activator and test compound, detecting expression of reporter gene products, adjustment in expression indicates modulation
09/12/2000US6117636 Screening for the presence fungi and yeast in a sample; amplifying nucleotide sequences using preferential primers and polymerase chain reaction, detecting amplification products
09/12/2000US6117635 Nucleotide sequence with fluorescein or derivative attached to 5' terminal and 4(4'-dimethylaminophenylazo)benzoic acid attached to nucleotide 22; for ?closed tube? format which decreases possibility of carryover contamination
09/12/2000US6117634 Nucleic acid sequencing and mapping
09/12/2000US6117632 Detection of protein sequences which transfer compounds across human and animal tissues; incubation of phage with tissue, recover transported phage, amplify, repeat process with recovered phage, detect transport protein sequences
09/12/2000US6117631 Screening for immunogens; immobilizing an immunogen to a solid support, incubation in solution with antibodies, incubation with immunodendrimer, screen for bound immunodendrimer
09/12/2000US6117398 System for releasing and isolating nucleic acids
09/12/2000US6117289 Cholesterol sensor and method for producing the same
09/12/2000CA2299675A1 Method for hla class ii typing
09/12/2000CA2087610C Biologically safe plant transformation system
09/12/2000CA2087105C Non-corrosive composition and methods useful for the extraction of nucleic acids
09/08/2000WO2000052480A1 Method for assaying biological sample component
09/08/2000WO2000052479A2 Diagnostics and therapeutics for drusen associated ocular disorders
09/08/2000WO2000052476A1 Method for diagnosing and distinguishing stroke
09/08/2000WO2000052467A1 Methods of determining altered ndpk functions
09/08/2000WO2000052456A1 Biosensor device and method
09/08/2000WO2000052210A2 Methods for targeting rna molecules
09/08/2000WO2000052209A1 Microarrays for identifying pathway activation or induction
09/08/2000WO2000052208A2 Customized oligonucleotide microchips that convert multiple genetic information to simple patterns
09/08/2000WO2000052207A1 Nucleic acid ligand inhibitors to dna polymerases
09/08/2000WO2000052206A1 Detection and quantification of micro-organisms using amplification and restriction enzyme analysis
09/08/2000WO2000052205A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE
09/08/2000WO2000052204A2 Gene expression in bladder tumors
09/08/2000WO2000052203A2 Identification of bacteria by amplification and probing
09/08/2000WO2000052202A2 Detection of monilinia spp. using the polymerase chain reaction
09/08/2000WO2000052201A2 Test system for detecting a splicing reaction and use thereof
09/08/2000WO2000052200A1 METHOD FOR LARGE SCALE cDNA CLONING AND SEQUENCING BY CIRCULATING SUBTRACTION
09/08/2000WO2000052199A1 Determination of biologically active forms of proteolytic enzymes
09/08/2000WO2000052198A1 Methods for identifying compounds useful for inhibiting farnesyl diphosphate synthase
09/08/2000WO2000052196A1 Method to detect antimicrobial agent resistant microbes
09/08/2000WO2000052195A1 Viability assay for sporocyst-forming protozoa
09/08/2000WO2000052194A2 Methods for detecting membrane derived caspase activity and modulators thereof
09/08/2000WO2000052180A1 Methods for generating and screening novel metabolic pathways
09/08/2000WO2000052165A2 Compositions and methods for breast cancer therapy and diagnosis
09/08/2000WO2000052163A1 Cloning of cdna of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer
09/08/2000WO2000052142A2 Culture medium comprising meiosis activating sterols (mas) and method for in vitro fertilisation
09/08/2000WO2000052140A1 Assays for inhibitors of ftsh
09/08/2000WO2000052137A2 Plant ligand-gated ion channels
09/08/2000WO2000052046A1 Immunomodulating glycopeptide
09/08/2000WO2000052044A1 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
09/08/2000WO2000052035A1 Bacterial transglycosylases: assays for monitoring the activity using lipid ii substrate analogs and methods for discovering new antibiotics
09/08/2000WO2000052022A1 Secreted proteins and nucleic acids encoding them
09/08/2000WO2000051642A1 Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease
09/08/2000WO2000051621A1 Method for validating/invalidating target(s) and pathways
09/08/2000WO2000051430A1 Human fas
09/08/2000WO2000036097A3 Methods for regulating vascularization using gef containing nek-like kinase (gnk)
09/08/2000WO2000034789A3 Method for determining asthma susceptibility
09/08/2000WO2000032811A3 Method for determining the apolipoprotein-e-genotype in a human sample
09/08/2000WO2000029847A3 Device and method for analyzing a biologic sample
09/08/2000WO2000029583A3 Immunoglobulin superfamily proteins
09/08/2000WO2000028070A3 Detection of prostatitis
09/08/2000WO2000026415A3 A method for genomic substractive hybridization
09/08/2000WO2000019883A3 Compositions and methods of disease diagnosis and therapy
09/08/2000WO2000019206A9 Ykl-40 as a marker and prognostic indicator for cancers
09/08/2000WO2000018960A3 Methods and products related to genotyping and dna analysis
09/08/2000WO2000018238A9 Identification of differentially methylated and mutated nucleic acids
09/08/2000WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof